title: Coreceptor change appears after immune deficiency is established in children infected with different HIV-1 subtypes.
abstract: Change of HIV-1 coreceptor use has been connected to progression of disease in children infected with HIV-1, presumably subtype B. It has not been possible to discern whether the appearance of new viral phenotypes precedes disease development or comes as a consequence of it. We studied the evolution of coreceptor use in HIV-1 isolates from 24 vertically infected children. Their clinical, virological, and immunological status was recorded and the env V3 subtype was determined by DNA sequencing. Coreceptor use was tested on human cell lines, expressing CD4 together with CCR5, CXCR4, and other chemokine receptors. The children carried five different env subtypes (nine A, five B, four C, three D, and one G) and one circulating recombinant form, CRF01_AE (n = 2). Of the 143 isolates, 86 originated from peripheral blood mononuclear cells (PBMCs) and 57 originated from plasma, received at 90 time points. In 52 of 54 paired plasma and PBMC isolates the coreceptor use was concordant. All 74 isolates obtained at 41 time points during the first year of life used CCR5. A change from use of CCR5 to use of CXCR4 occurred in four children infected with subtype A, D, or CRF01_AE after they had reached 1.5 to 5.8 years of age. There was a significant association with decreased CD4+ cell levels and severity of disease but, interestingly, the coreceptor change appeared months or even years after the beginning of the immunological deterioration. Thus CXCR4-using virus may emerge as a possible consequence of immune deficiency. The results provide new insights into AIDS development in children.
authors.affiliation: Microbiology and Tumor Biology Center, Karolinska Institutet, SE-171 77 Stockholm, Sweden.
authors.forename: C
authors.initials: C
authors.lastname: Casper
authors.forename: L
authors.initials: L
authors.lastname: Navér
authors.forename: P
authors.initials: P
authors.lastname: Clevestig
authors.forename: E
authors.initials: E
authors.lastname: Belfrage
authors.forename: T
authors.initials: T
authors.lastname: Leitner
authors.forename: J
authors.initials: J
authors.lastname: Albert
authors.forename: S
authors.initials: S
authors.lastname: Lindgren
authors.forename: C
authors.initials: C
authors.lastname: Ottenblad
authors.forename: A-B
authors.initials: AB
authors.lastname: Bohlin
authors.forename: E M
authors.initials: EM
authors.lastname: Fenyö
authors.forename: A
authors.initials: A
authors.lastname: Ehrnst
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000175:diagnosis / Q000378:metabolism* / Q000635:transmission / Q000821:virology; D001483:Base Sequence; D018791:CD4 Lymphocyte Count; D002460:Cell Line; D002648:Child; D002675:Child, Preschool; D005260:Female; D015497:HIV-1 / Q000145:classification / Q000302:isolation & purification* / Q000472:pathogenicity; D006801:Humans; D007223:Infant; D018445:Infectious Disease Transmission, Vertical; D007963:Leukocytes, Mononuclear / Q000821:virology; D008895:Milk, Human / Q000821:virology; D010641:Phenotype; D010802:Phylogeny; D011247:Pregnancy; D011446:Prospective Studies; D019707:Receptors, Chemokine / Q000378:metabolism*; D015728:Receptors, HIV / Q000378:metabolism*; D013997:Time Factors; D014779:Virus Replication
chemical_list: D019707:Receptors, Chemokine; D015728:Receptors, HIV